Advertisement

Topics

LivaNova Finishes Feasibility Trial Of Transcatheter Mitral Valve, Anticipates 2020 CE Mark

13:28 EDT 12 Aug 2018 | SCRIP

<p>The PRELUDE feasibility study of LivaNova's Caisson transseptal transcatheter mitral valve replacement (TMVR) system is complete and the company the...

      

Related Stories

 

Original Article: LivaNova Finishes Feasibility Trial Of Transcatheter Mitral Valve, Anticipates 2020 CE Mark

NEXT ARTICLE

More From BioPortfolio on "LivaNova Finishes Feasibility Trial Of Transcatheter Mitral Valve, Anticipates 2020 CE Mark"

Advertisement
Quick Search
Advertisement
Advertisement